Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Makenzie Danton"'
Autor:
Gavin Thurston, Richard Tavare, Marcus P Kelly, Sosina Makonnen, Carlos Hickey, T Cody Arnold, Jason T Giurleo, Makenzie Danton, Christian Granados, Ishita Chatterjee, Drew Dudgeon, Marc W Retter, Dangshe Ma, William C Olson, Jessica R Kirshner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/e9dd493986824827a77c38864a866af9
Autor:
Gavin Thurston, Richard Tavare, Marcus P Kelly, Sosina Makonnen, Carlos Hickey, T Cody Arnold, Jason T Giurleo, Makenzie Danton, Christian Granados, Ishita Chatterjee, Drew Dudgeon, Marc W Retter, Dangshe Ma, William C Olson, Jessica R Kirshner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Background Programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) blocking antibodies including cemiplimab have generated profound clinical activity across diverse cancer types. Tumorous PD-L1 expression, as assessed by immunohistoche
Externí odkaz:
https://doaj.org/article/95ca884fb1ff45408c623ba0079af2dc
Autor:
Jessica R. Kirshner, Dangshe Ma, Gavin Thurston, William C. Olson, Adam Griesemer, Akiva Mintz, Jon Popke, Lynn E. Macdonald, Andrew Murphy, Hans Gartner, Naxin Tu, Cagan Gurer, Christos A. Kyratsous, Thomas Barry, Mikhail Doubrovin, Nikunj B. Bhatt, Drew Dudgeon, Terra Potocky, Kurt H. Edelmann, Erica Ullman, Aynur Hermann, Karina Bruestle, Fanny Fredriksson, Marcus P. Kelly, Tomas C. Arnold, Carlos Hickey, Sosina Makonnen, Jason T. Giurleo, Makenzie Danton, Richard Tavaré
Assessment of immune-cell subsets within the tumor immune microenvironment is a powerful approach to better understand cancer immunotherapy responses. However, the use of biopsies to assess the tumor immune microenvironment poses challenges, includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a28c1ce088d993bb73c7f8fe1e2f64
https://doi.org/10.1158/2326-6066.c.6550910.v1
https://doi.org/10.1158/2326-6066.c.6550910.v1
Autor:
Alison Crawford, Jessica R. Kirshner, Gavin Thurston, Eric Smith, Dangshe Ma, Jason T. Giurleo, Pamela Krueger, Sumreen Jalal, Jennifer Finney, Makenzie Danton, Priyanka Ram, Kristin Vazzana, Olulanu H. Aina, Lauric Haber, Richard Tavaré, Danica Chiu
Supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90be1b820eb9b214932b71972d26d15a
https://doi.org/10.1158/2326-6066.22543602.v1
https://doi.org/10.1158/2326-6066.22543602.v1
Autor:
Jessica R. Kirshner, Dangshe Ma, Gavin Thurston, William C. Olson, Adam Griesemer, Akiva Mintz, Jon Popke, Lynn E. Macdonald, Andrew Murphy, Hans Gartner, Naxin Tu, Cagan Gurer, Christos A. Kyratsous, Thomas Barry, Mikhail Doubrovin, Nikunj B. Bhatt, Drew Dudgeon, Terra Potocky, Kurt H. Edelmann, Erica Ullman, Aynur Hermann, Karina Bruestle, Fanny Fredriksson, Marcus P. Kelly, Tomas C. Arnold, Carlos Hickey, Sosina Makonnen, Jason T. Giurleo, Makenzie Danton, Richard Tavaré
Supplementary Data from Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc99ef8fb49a9843c409980f336132eb
https://doi.org/10.1158/2326-6066.22545326.v1
https://doi.org/10.1158/2326-6066.22545326.v1
Autor:
Alison Crawford, Jessica R. Kirshner, Gavin Thurston, Eric Smith, Dangshe Ma, Jason T. Giurleo, Pamela Krueger, Sumreen Jalal, Jennifer Finney, Makenzie Danton, Priyanka Ram, Kristin Vazzana, Olulanu H. Aina, Lauric Haber, Richard Tavaré, Danica Chiu
Patients with hematologic cancers have improved outcomes after treatment with bispecific antibodies that bind to CD3 on T cells and that redirect T cells toward cancer cells. However, clinical benefit against solid tumors remains to be shown. We made
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c35e7d21e92f6019bfca787dcc9c83
https://doi.org/10.1158/2326-6066.c.6550329.v1
https://doi.org/10.1158/2326-6066.c.6550329.v1
Autor:
Richard Tavaré, Makenzie Danton, Jason T. Giurleo, Sosina Makonnen, Carlos Hickey, Tomas C. Arnold, Marcus P. Kelly, Fanny Fredriksson, Karina Bruestle, Aynur Hermann, Erica Ullman, Kurt H. Edelmann, Terra Potocky, Drew Dudgeon, Nikunj B. Bhatt, Mikhail Doubrovin, Thomas Barry, Christos A. Kyratsous, Cagan Gurer, Naxin Tu, Hans Gartner, Andrew Murphy, Lynn E. Macdonald, Jon Popke, Akiva Mintz, Adam Griesemer, William C. Olson, Gavin Thurston, Dangshe Ma, Jessica R. Kirshner
Publikováno v:
Cancer Immunol Res
Assessment of immune-cell subsets within the tumor immune microenvironment is a powerful approach to better understand cancer immunotherapy responses. However, the use of biopsies to assess the tumor immune microenvironment poses challenges, includin
Autor:
Dilrukshi Ekanayake-Alper, Shunichiro Nomura, A. Asfour, Hironosuke Watanabe, Kazuhiko Yamada, Hisashi Sahara, Tatsu Tanabe, Akira Shimizu, A. Dardenne Meyers, Jigesh A. Shah, David H. Sachs, Makenzie Danton, Lennan K Boyd
Publikováno v:
American Journal of Transplantation. 17:1778-1790
In our studies of life-supporting α-1,3-galactocyltransferase knockout (GalT-KO) pig-to-baboon kidneys, we found that some recipients developed increased serum creatinine with growth of the grafts, without histological or immunological evidence of r
Autor:
Genevieve Pierre, Diane Ordanes, Paula Alonso-Guallart, Dilrukshi Ekanayake-Alper, Megan Sykes, Erik Berglund, Jay H. Lefkowitch, Makenzie Danton, Fanny Fredriksson, Yojiro Kato, Tomoaki Kato, Nathaly Llore, Hiroshi Sakai, Alina Iuga, Mercedes Martinez, Adam Griesemer, Karina Bruestle, Joshua Weiner, Jeffrey Stern, Sulemon Chaudhry, Sigal Kofman
Publikováno v:
Transplantation. 104:S153-S154
Autor:
Felix Sellberg, Megan Sykes, David Berglund, Keith A. Reimann, Robin Fröbom, David H. Sachs, Paula Alonso-Guallart, Nathaly Llore, Christian Binder, Makenzie Danton, Erik Berglund, Adam Griesemer, Alina Iuga, Hiroshi Sakai, Dilrukshi Ekanayake-Alper
Publikováno v:
Transpl Int
BACKGROUND: Anti-CD2 treatment provides targeted immunomodulatory properties that have demonstrated clinical usefulness to condition the immune system and to treat transplant rejection. The treatment is species-specific due to structural CD2 antigen